KALA BIO, Inc. (KALA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated October 19, 2025, details a critical liquidity event and operational cessation for KALA BIO, Inc. Following a September 28, 2025, decision to cease development of its KPI-012 program and mesenchymal stem cell secretome platform to preserve cash, the Company faced an event of default with its secured lender, Oxford Finance LLC ("Oxford").
Key Financial Metrics and Liquidity
- Cash Position: Oxford has swept substantially all of the Company's cash resources from its bank accounts.
- Debt Obligations: After applying swept cash to secured debt claims, Oxford continues to be owed approximately $9.6 million by the Company.
- Liquidity Constraints: Oxford has restricted the Company's use of remaining cash to minimal payroll expenses pending foreclosure.
- Revenue/Profit: The filing text does not provide specific revenue, profit, or margin figures for the current period.
Material Changes and Operational Impact
- Foreclosure Initiation: On October 18, 2025, Oxford notified the Company of its intent to foreclose on all remaining assets.
- Workforce Reduction: On October 19, 2025, the Board terminated all remaining employees not deemed necessary by Oxford to execute the foreclosure.
- Executive Departure: Todd Bazemore, President and CEO, was terminated without cause effective immediately. He will continue to serve as a director and principal executive officer.
- Reporting Cessation: The Company does not expect to be able to continue filing SEC reports, including the Q3 2025 Form 10-Q and the 2025 Form 10-K.
- Delisting: The Company expects its common stock to be delisted from The Nasdaq Capital Market.
- Verify the exact status of the foreclosure proceedings with Oxford Finance LLC.
- Confirm the official delisting date of KALA stock from The Nasdaq Capital Market.
- Review the valuation of remaining noncash assets to assess potential recovery for unsecured creditors.
- Monitor for any subsequent filings regarding the dissolution of the Company.
- Check for any updates on the $9.6 million secured debt claim status.
Outlook, Risks, and Contingencies
Management believes that unless the foreclosure on noncash assets generates proceeds exceeding Oxford's remaining $9.6 million claim, no distributions will be available to stockholders or unsecured creditors. The Company faces significant uncertainty regarding the timing and result of the foreclosure process and its ability to continue operations.